Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKinsey
Merck
Express Scripts
Mallinckrodt

Last Updated: December 9, 2021

DrugPatentWatch Database Preview

Litigation Details for NOVEN PHARMACEUTICALS v. WATSON LABORATORIES, INC. (D.N.J. 2011)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in NOVEN PHARMACEUTICALS v. WATSON LABORATORIES, INC.
The small molecule drug covered by the patents cited in this case is ⤷  Try it Free .

Details for NOVEN PHARMACEUTICALS v. WATSON LABORATORIES, INC. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2013-07-09 Invalidity of Asserted Claims of US Patent No 6,210,705. Motion set for 9/16/2013 before Judge Dennis…MOTION for Summary Judgment Non-Infringement of US Patent No 6,348,211, 120 MOTION for Summary Judgment Invalidity…2011 25 March 2014 2:11-cv-05997 830 Patent Defendant District Court, D. New Jersey External link to document
2013-06-06 116 in U S Patent No 6 210 705 (the 705 patent ) and U.S. Patent No. 6,348,211 (the “211 patent”) (collectively…collectively the “patents-in-suit”), The patents-in-suit are directed to the Daytrana…Watson”), a Markman hearing, PU1’SUant to Local Patent Rule 4.5, was held before this Court on December…mean 0-70 subject to rounding errors. Again, the patent speciflcation “uses integers in 1% incremenets…. Amended Markman Opinion, pg 9-10 (citing 21 1 patent. col. 8. 1.26-col, 10, Examples 1-29)). While External link to document
2013-07-08 120 Judgment Invalidity of Asserted Claims of US Patent No 6,210,705 by WATSON LABORATORIES, INC., Watson Pharmaceuticals…2011 25 March 2014 2:11-cv-05997 830 Patent Defendant District Court, D. New Jersey External link to document
2013-07-08 121 Summary Judgment Non-Infringement of US Patent No 6,348,211 by WATSON LABORATORIES, INC., Watson Pharmaceuticals…2011 25 March 2014 2:11-cv-05997 830 Patent Defendant District Court, D. New Jersey External link to document
2013-07-08 122 Judgment Invalidity of Asserted Claims of US Patent No 6,210,705 (Attachments: # 1 Statement Material Facts…2011 25 March 2014 2:11-cv-05997 830 Patent Defendant District Court, D. New Jersey External link to document
2013-07-08 123 Summary Judgment Non-Infringement of US Patent No 6,348,211 (Attachments: # 1 Statement Material Facts…2011 25 March 2014 2:11-cv-05997 830 Patent Defendant District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
McKesson
Merck
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.